Meninges: A Comprehensive Review and Clinical Relevance in Health and Disease
1. Toichieva Zarina Jamaldinovna
2. Ahmed Rezaul
Ahmed Injamamul
Ansari Rakibul
Islam Mafizul
(1. Professor, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
2. Students, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic)
Abstract
The meninges, the three membranous layers that envelop the brain and spinal cord, have long been regarded as passive protective coverings of the central nervous system. However, recent advances in neuroanatomy, immunology, and molecular biology have fundamentally transformed this perspective, revealing the meninges as a dynamic, multifunctional interface essential for central nervous system homeostasis, immune surveillance, waste clearance, and neurodevelopment. This review synthesizes current knowledge on the structural organization, cellular composition, and functional roles of the cranial and spinal meninges, with particular emphasis on recent discoveries including meningeal lymphatic vessels, dural-associated lymphoid tissues, arachnoid cuff exit points, and the skull-meninges interface. We examine the embryological origins of meningeal layers, their histological architecture, and the molecular heterogeneity of meningeal fibroblasts as revealed by single-cell transcriptomics. The review further explores the emerging field of meningeal immunity, including the role of dural sinuses as immune surveillance hubs, the contribution of meningeal immune cells to neuroinflammatory and neurodegenerative diseases, and the integration of meningeal lymphatics with the glymphatic system for brain waste clearance. Clinical implications are discussed across a spectrum of meningeal disorders including meningitis, subdural hematoma, leptomeningeal disease, and meningioma, with attention to contemporary diagnostic and therapeutic approaches. By integrating classical anatomical knowledge with cutting-edge discoveries from multi-omics, advanced imaging, and clinical trials, this article provides a comprehensive framework for understanding the meninges as an active participant in central nervous system biology and a promising target for neurological therapeutics.
1. Introduction
The human brain, weighing approximately 1,400 grams in the adult, is one of the most metabolically active and structurally delicate organs in the body, yet it is housed within a rigid bony case that offers protection but also creates vulnerability to trauma, pressure changes, and inflammatory insults. The meninges represent the evolutionary solution to this paradox: a multilayered membranous system that cushions the central nervous system, maintains its chemical environment, facilitates immune surveillance, and provides structural support for the vast vascular network that sustains neural function. For centuries, the meninges were understood primarily through the lens of gross anatomy, appreciated as the dura mater, arachnoid mater, and pia mater—three layers whose Latin names evoke maternal protection and whose physical characteristics suggested a straightforward protective role. The dura, meaning "hard mother," appeared as a tough fibrous sheath; the arachnoid, the "spider-like" middle layer, seemed a delicate web; and the pia, the "tender mother," clung intimately to the neural surface like shrink wrap. This classical view, while anatomically accurate, profoundly underestimated the biological complexity and functional significance of these membranes.
The transformation of our understanding of the meninges from passive coverings to active neuroimmune interfaces represents one of the most exciting developments in contemporary neuroscience. The rediscovery of meningeal lymphatic vessels in 2015 challenged the long-standing dogma that the central nervous system lacks a lymphatic drainage system, forcing a fundamental reevaluation of how the brain communicates with the peripheral immune system and clears metabolic waste. Subsequent research has revealed organized lymphoid structures within the dura mater, direct channels connecting cranial bone marrow to the meninges, and specialized cellular interfaces that enable bidirectional immune cell trafficking between the brain and its surrounding tissues. Single-cell transcriptomic analyses have uncovered remarkable heterogeneity among meningeal fibroblasts, demonstrating that cells of the pia, arachnoid, and dura are molecularly distinct populations with specialized functions in extracellular matrix production, barrier maintenance, and immune modulation. These discoveries have illuminated the meninges as a critical hub in the brain's waste clearance network, a gatekeeper of neuroimmune communication, and a participant in cognitive processes ranging from learning and memory to the pathogenesis of neurodegenerative diseases.
The clinical relevance of these advances extends across virtually every domain of neurology and neurosurgery. Meningitis, the inflammation of the meninges, remains a leading cause of infectious mortality worldwide, and our evolving understanding of meningeal immunity is reshaping approaches to prevention and treatment. Subdural hematoma, a common consequence of traumatic brain injury particularly in the elderly, reflects the unique anatomical vulnerability of bridging veins traversing the meningeal spaces. Leptomeningeal metastasis, the spread of systemic cancers to the cerebrospinal fluid compartments, represents a devastating complication with limited therapeutic options. Meningiomas, tumors arising from meningeal cells, are the most common primary intracranial neoplasms, and recent molecular classifications are revolutionizing their prognostic stratification and targeted therapy. In each of these conditions, contemporary research is revealing how the structural and functional properties of the meninges determine disease susceptibility, progression, and response to intervention.
We begin with the embryological development and anatomical organization of meningeal layers, followed by an examination of their histological architecture and cellular composition. We then explore the emerging understanding of meningeal immunity, lymphatic drainage, and neuroimmune interactions. The discussion extends to the glymphatic system and its integration with meningeal lymphatics for brain waste clearance. We subsequently review the pathophysiology, diagnosis, and management of major meningeal disorders, and conclude with an evaluation of emerging therapeutic strategies targeting meningeal pathways. Throughout, we emphasize the integration of classical anatomical knowledge with recent discoveries from advanced imaging, single-cell genomics, and clinical biomarker studies to provide an up-to-date and clinically relevant perspective on this rapidly evolving field.
2. Materials and Methods
This review was conducted through a comprehensive and systematic search of the published literature, with particular emphasis on peer-reviewed articles, systematic reviews, and meta-analyses indexed in PubMed/MEDLINE, the Cochrane Library, and relevant neuroscience, neurology, and neurosurgery journals. The search strategy employed a combination of MeSH terms and free-text keywords including "meninges," "meningeal anatomy," "meningeal immunity," "meningeal lymphatic vessels," "glymphatic system," "dura mater," "arachnoid mater," "pia mater," "subarachnoid space," "cerebrospinal fluid," "meningitis," "subdural hematoma," "leptomeningeal disease," "meningioma," "skull-meninges interface," "cranial bone marrow," "neuroimmune interactions," "brain waste clearance," "Alzheimer's disease," "multiple sclerosis," and "neurodegenerative disease." The search was restricted to articles published in English, with priority given to publications from 2019 to 2026 to ensure currency, though seminal earlier works were included where essential for historical context or foundational concepts. Additional articles were identified through manual screening of reference lists from retrieved papers and from recent review articles in high-impact journals.
The selection criteria favored original research articles reporting mechanistic insights into meningeal biology, clinical studies evaluating meningeal biomarkers or imaging techniques, and randomized controlled trials of therapies targeting meningeal or cerebrospinal fluid pathways. Animal model studies were included where they provided critical mechanistic insights with clear translational relevance to human disease. Case reports and opinion pieces were generally excluded unless they provided unique clinical perspectives or reported novel observations of exceptional significance. Data extraction focused on anatomical structures, cellular populations, molecular mechanisms, disease associations, and therapeutic outcomes. Where conflicting evidence existed, we prioritized findings from the most methodologically rigorous studies and acknowledged areas of uncertainty or ongoing debate. The synthesis of evidence was organized thematically to construct an integrated narrative highlighting the interconnectedness of meningeal biology across physiological and pathological contexts.
3. Results
3.1 Embryological Development and Origins of the Meninges
The development of the meninges is intimately linked to the formation of the neural tube and the surrounding cranial mesenchyme, with distinct embryological origins contributing to different meningeal layers and regions. Understanding these developmental origins is essential for appreciating the regional heterogeneity of meningeal structure and function, as well as the basis for certain congenital anomalies. The central nervous system develops from the neuroectoderm, which folds to form the neural tube during the third and fourth weeks of gestation. As the neural tube closes, the surrounding mesenchyme condenses to form the primitive meninx, which subsequently differentiates into the three definitive meningeal layers. The embryological origins of these cells have been elucidated through elegant experiments using quail-chick chimeras and, more recently, Cre-loxP lineage tracing in mice, revealing a complex interplay between neural crest-derived and mesoderm-derived populations.
Early experiments on quail and chick chimeras demonstrated that neural crest-derived cells, generated from the caudal forebrain and midbrain levels, contributed to the meninges associated with the forebrain, whereas mesoderm-derived cells gave rise to the meninges of the midbrain and hindbrain. In all areas, however, the endothelial cells of meningeal blood vessels were strictly of mesodermal origin, highlighting the diverse cellular sources that contribute to the mature meningeal vasculature. Histological observations in human fetuses have similarly suggested that the cranial meninges originate from both neural crest and mesoderm, with the prechordal plate and paraxial mesoderm identified as key sources of mesodermal cells. These findings established a fundamental principle of meningeal development: the forebrain meninges are predominantly neural crest-derived, while the midbrain and hindbrain meninges are primarily mesodermal in origin, a pattern that has significant implications for understanding regional differences in meningeal biology and disease susceptibility.
In mice, lineage tracing using Wnt1-Cre, which is active in the neural crest, has confirmed that neural crest-derived cells populate all three layers of the meninges associated with the forebrain cerebral hemispheres but are absent from the meninges covering the midbrain and hindbrain. Conversely, mesoderm-specific Mesp1-Cre tracing has provided positive evidence that the meninges of the midbrain and hindbrain are of mesodermal origin, while the forebrain meninges are of neural crest origin, with the exception of endothelial cells. This regional patterning is not merely of academic interest; it may underlie the differential susceptibility of anterior versus posterior meninges to certain pathological processes and could explain why some meningeal tumors, such as meningiomas, show preferential distributions that correlate with their molecular subtypes. The skull itself shows a similar regional pattern of neural crest versus mesodermal contribution, though the boundary between these populations differs between the skull and the overlying meninges, creating complex tissue interfaces that may influence developmental and pathological processes.
Multiple intercellular signaling pathways regulate normal meningeal development, with transforming growth factor beta signaling being among the most critical. In mouse embryos with neural crest-specific deletion of Tgfbr2, which encodes a transforming growth factor beta receptor component, the forebrain meninges fail to develop properly and are replaced by only a single layer of non-proliferating cells. Wingless-integrated signaling and retinoic acid signaling also influence meningeal development, with constitutive activation of the WNT-beta-catenin pathway promoting expansion of the meningeal layer through increased cell proliferation. Interestingly, retinoic acid signaling appears to be dispensable for normal meningeal development, though its overactivation is deleterious, causing thin and discontinuous meninges. These signaling pathways not only regulate the initial formation of meningeal layers but also influence their subsequent maturation, vascularization, and acquisition of specialized barrier properties.
The spinal meninges follow a somewhat different developmental trajectory. The spinal cord meninges are believed to derive from several sources including the prechordal plate, unsegmented paraxial mesoderm, segmented somitic mesoderm, neural crest, neurilemmal cells, and even the neural tube itself. Some of these sources pertain specifically to the cranial meninges, others to the spinal coverings, reflecting the distinct embryological environments of the developing brain and spinal cord. The first of the future dural processes to develop is the tentorium cerebelli, which at the end of the embryonic period proper differs considerably in shape and composition from the later fetal and postnatal tentorium. The embryonic dural limiting layer, corresponding to the interface layer of the adult meninges, represents an early specialization that prefigures the complex barrier functions of the mature arachnoid mater. These developmental processes establish the structural and functional foundations upon which all subsequent meningeal biology depends.
3.2 Gross Anatomy and Structural Organization of Meningeal Layers
The meninges are conventionally described as three distinct layers: the dura mater, the arachnoid mater, and the pia mater, which together create three clinically significant spaces—the epidural, subdural, and subarachnoid spaces. While this tripartite classification remains anatomically valid, recent research has revealed considerably more complexity within each layer, including previously unrecognized sublayers, specialized cellular populations, and novel structural adaptations that serve specific physiological functions. The cranial meninges, which envelop the brain, show important differences from the spinal meninges, which surround the spinal cord, and these differences have direct clinical implications for the pathophysiology and management of meningeal disorders.
The dura mater, the outermost and toughest meningeal layer, is composed of dense fibrous connective tissue that adheres to the inner surface of the skull and, in the spinal canal, to the periosteum of the vertebral column. In the cranium, the dura consists of two layers: an outer periosteal layer that is firmly attached to the inner table of the skull, and an inner meningeal layer that faces the arachnoid mater. These two layers are typically fused with no distinct border between them, except at sites of dural infoldings where they are separated by endothelium-lined dural venous sinuses. The periosteal layer contains large blood vessels located almost exclusively in its inner part, while the meningeal layer has smaller, more abundant vessels positioned at the border with the underlying dural border cell layer. The cranial dura mater in humans has an average thickness of approximately 564 micrometers and is composed of wavy collagen bundles arranged into two concentric layers, with fibroblasts entrapped between these bundles and interposed among the fibers. A network of randomly arranged elastic fibers, occupying approximately 1.7 percent of the cranial dura mater, is interposed between the collagen bundles and is more abundant in the periosteal layer than in the meningeal layer.
A critical but often underappreciated component of the cranial dura is the dural border cell layer, also referred to as the inner dural cell layer, subdural cell layer, subdural compartment, or dural limiting layer. This innermost layer of the dura is composed of loosely arranged, three to eight layers of flattened fibroblasts exhibiting long processes that are occasionally attached by a few desmosomes and gap junctions. Surprisingly, collagen fibers are entirely absent from this layer, which instead contains a copious amount of extracellular proteoglycan in spaces of varying size and shape. This loose arrangement, wide extracellular spaces, and absence of collagen fibrils render the dural border cell layer a plane of structural weakness at the dura-arachnoid interface. In pathological conditions, bleeding dissects this plane freely, creating a pathological subdural space that is not normally present in healthy individuals. The hematoma formed in these cases has the classical long, thin crescent shape on imaging, a radiological signature that reflects the anatomical properties of this layer. The dural border cell layer was originally mistaken for mesothelial cells, hence the alternative names mesothelial layer or neurothelium, but modern ultrastructural studies have clarified its true fibroblastic nature.
The spinal dura mater differs from its cranial counterpart in several important respects. While the cranial dura has two layers, the spinal dura mater possesses only the deep meningeal layer; the periosteal layer ends at the foramen magnum, with only the meningeal layer continuing down along the spinal cord. The spinal dura attaches superiorly to the tectorial membrane and posterior longitudinal ligament and extends inferiorly to approximately the S2 vertebral level, thus continuing well below the termination of the spinal cord at L1-L2. The space between the spinal dura mater and the periosteum of the vertebral column constitutes the spinal epidural space, which contains loose connective and adipose tissues, the anterior and posterior internal vertebral venous plexuses, and spinal nerve roots as they exit the dural sac. This space is clinically significant as the site for epidural anesthesia and as a potential route for the spread of infection and metastatic disease.
The dura mater folds inward upon itself to form four major fibrous septa that partition the cranial cavity and house the dural venous sinuses. The falx cerebri separates the left and right cerebral hemispheres and contains the superior and inferior sagittal sinuses. The tentorium cerebelli separates the cerebrum from the cerebellum and houses the transverse, straight, and superior petrosal sinuses. The falx cerebelli separates the two cerebellar hemispheres and contains the occipital sinus. The diaphragma sellae forms a roof over the hypophyseal fossa within which the pituitary gland sits and contains the anterior and posterior intercavernous sinuses. These dural reflections are not merely structural partitions; they create anatomical compartments with distinct pressure dynamics, influence the pattern of intracranial mass effect and herniation, and serve as attachment points for important venous drainage pathways. The dural venous sinuses themselves are unique vascular structures that differ from systemic veins in having no tunica media, tunica adventitia, or valves, but possessing an evident internal elastic lamina. They serve as the major drainage route for cerebral venous blood and as sites of cerebrospinal fluid absorption through arachnoid granulations.
The arachnoid mater, the middle meningeal layer, is a thin, avascular membrane that lies between the dura and pia mater. Unlike the pia mater, the arachnoid does not follow the contours of the cortical sulci but bridges across them, creating the subarachnoid cisterns at the base of the brain where the space between arachnoid and pia is considerably enlarged. The arachnoid consists of a superficial mesothelial layer below the dura, a central layer composed of cells conjoined by numerous junction proteins, and a deep layer of less tightly packed cells with many collagen fibers within their intercellular space. The arachnoid barrier is sealed by tight junctions composed of claudin-11, which function to compartmentalize the cerebrospinal fluid and prevent unregulated exchange between the subarachnoid space and the dura. Arachnoid trabeculae extend into the subarachnoid space and merge with the underlying pia mater, giving the subarachnoid space its characteristic spiderweb appearance and providing structural support for the cerebral vessels that course through this compartment.
A major recent discovery has been the identification of arachnoid cuff exit points, specialized structures where bridging veins penetrate the arachnoid barrier to reach the dural venous sinuses. These points represent discontinuities in the otherwise impermeable arachnoid layer, creating critical control checkpoints at the central nervous system gateway that allow direct fluid and cell exchange between the dura and the subarachnoid space. Arachnoid cuff exit points facilitate cerebrospinal fluid drainage while simultaneously restricting molecular entry from the dura into the subarachnoid space, representing a sophisticated bidirectional control mechanism. They are closely associated with meningeal lymphatic vessels, and once cerebrospinal fluid reaches the dura through these points, it can be rapidly drained by the lymphatic system. This association suggests a potential role for arachnoid cuff exit points in facilitating the clearance of large molecular waste from the subarachnoid space into the dura, a function that could be particularly significant in conditions such as traumatic brain injury or subarachnoid hemorrhage where efficient debris clearance is crucial. Cellular transport through arachnoid cuff exit points is mediated by laminin, which guides the migration of myeloid cells from the dura into the subarachnoid space, providing a novel explanation for the interaction between the seemingly barrier-isolated central nervous system and the peripheral immune system.
The pia mater, the innermost meningeal layer, is a very thin, highly vascularized membrane that directly adheres to the surface of the brain and spinal cord, following all contours of the gyri and sulci. Unlike the avascular arachnoid, the pia contains numerous blood vessels that perforate through the membrane to supply the underlying neural tissue. The pia is composed of two layers: an outer epipial layer containing collagen fibers that connects to the arachnoid mater via arachnoid trabeculae, and an inner intima pia containing elastic and reticular fibers that adheres to the outermost layer of neural tissue known as the glial membrane. The cerebral pia mater forms sheaths around blood vessels entering and exiting the brain, creating the perivascular or Virchow-Robin spaces between the vessel walls and the pial sheath. These perivascular spaces are critically important as conduits for cerebrospinal fluid and interstitial fluid exchange, immune cell trafficking, and waste clearance from the brain parenchyma. In the spinal cord, the pia mater gives off the denticulate ligaments, twenty-one pairs of ligamentous lateral projections that pass through the arachnoid and attach to the spinal dura mater, serving to position and hold the spinal cord in place. From the apex of the conus medullaris, the pia continues as the filum terminale, a fibrous projection extending approximately twenty centimeters downward to attach to the periosteum of the first coccygeal vertebra.
3.3 Histological Architecture and Cellular Composition
The histological structure of the meninges reveals a complex tissue architecture that supports their diverse functional roles. The cranial dura mater, as visualized in routine hematoxylin and eosin-stained sections, is formed of wavy collagen bundles arranged into concentric layers corresponding to the periosteal and meningeal dura. Fibroblasts are entrapped between these collagen bundles and interposed among the fibers. By electron microscopy, the periosteal dura contains two cell types: osteoprogenitor cells and large elongated fibroblasts. The collagen fibers of this layer are organized into bundles that are loosely attached to the inner surface of the skull, except at suture lines and the base of the skull where attachment is firm. With advancing age, the cranial dura becomes thicker, tougher, and more adherent to the skull, a change that has implications for neurosurgical approaches and for the pathophysiology of conditions such as chronic subdural hematoma. The meningeal dura, in contrast, has more cellular and less fibrous components than its periosteal counterpart, with smaller, darker, more elongated fibroblasts and collagen fibers arranged in sheets rather than bundles.
The arachnoid mater has been described as having an inner layer that is part of the dura mater in some mechanical studies, with trabeculae inserted into the pia mater and cells similar to those in the dura mater structure. The arachnoid barrier cells are joined by tight junctions that create a seal against the dura, while the deeper layers become progressively less organized and more permeable. The pia mater contains a large amount of collagen fibers, a few elastin fibers, an amorphous intracellular substance, small vessels, fibroblasts, and macrophages. It has several layers including subpial tissues with collagen fibers and pial cellular layers from neuroglial cells surrounding the spinal cord. The fenestrated nature of the pia in the lumbar spine has been documented using histology and microscopy techniques, revealing structural specializations that may facilitate fluid and cellular exchange in this region.
Recent single-cell transcriptomic analyses have revolutionized our understanding of meningeal cellular heterogeneity, demonstrating that fibroblasts of the pia, arachnoid, and dura are distinct populations with unique gene expression profiles. These analyses have revealed that meningeal fibroblasts are not a uniform cell type but comprise multiple subpopulations distributed across meningeal layers, each with specialized functions in extracellular matrix production, barrier maintenance, and immune modulation. The heterogeneity among embryonic meningeal fibroblasts suggests that these distinct subpopulations are established early in development and are maintained into adulthood, providing a cellular basis for the regional functional specializations observed in different meningeal compartments. This molecular diversity has important implications for understanding how meningeal layers respond differently to injury, inflammation, and disease, and may explain why certain pathological processes preferentially affect specific meningeal regions.
The non-immune cellular constituents of the meninges extend beyond fibroblasts to include endothelial cells lining the dural venous sinuses and meningeal blood vessels, pericytes, smooth muscle cells, and mesothelial-like cells. The stromal niche of the dura contains endothelial populations and mural subtypes that closely regulate homeostatic tissue immunity. Dural stromal cells have been shown to express chemokines such as CXCL12, which contributes to the recruitment of circulating T cells into the dura through CXCR4 signaling. This stromal-immune cell crosstalk is essential for maintaining the immune surveillance functions of the meninges and is dynamically regulated during aging and neuroinflammatory conditions. The discovery that meningeal fibroblasts and stromal cells actively participate in immune regulation represents a paradigm shift from the traditional view of these cells as passive structural elements.
3.4 Meningeal Innervation and Vascular Supply
The cranial dura mater receives its primary sensory innervation from the trigeminal nerve, with additional contributions from the vagus nerve, upper cervical spinal nerves, and the sympathetic trunk. The trigeminal nerve provides sensory innervation to the intracranial dura mater through its ophthalmic, maxillary, and mandibular divisions, with the nervus spinosus comprising meningeal branches from the maxillary and mandibular divisions forming a dense plexus along the middle meningeal artery in the middle cranial fossa. Activation of dural sensory fibers is regarded as pivotal for the generation of pain experienced in some types of headache, including migraine, where the pathogenesis is generally explained by activation of meningeal nociceptors following stimulation of meningeal arteries or venous sinuses. Mechanical, electrical, and heat stimulation of the cranial dura mater results in pain localized to specific areas of the head, with the precise localization dependent on the site of dural stimulation. Stimulation of the dura in the middle cranial fossa adjacent to branches of the middle meningeal artery produces pain in the ipsilateral temporal, retroorbital, and frontal regions, while stimulation of the floor of the anterior cranial fossa causes pain in the ipsilateral retroorbital region. Stimulation of the superior surface of the tentorium or straight sinus results in referred pain to the ipsilateral forehead and periorbital regions. The posterior cranial fossa dura receives innervation from several different sources, including the upper cervical nerves, which explains why posterior fossa pathology can cause occipital and neck pain.
The middle meningeal artery, a branch of the maxillary artery, is the principal arterial supply to the cranial dura mater, entering the skull through the foramen spinosum and branching extensively across the inner table of the skull. The dura also receives blood from the ascending pharyngeal artery, the occipital artery, and the vertebral artery. The arterial supply of the spinal dura is derived from segmental arteries that accompany the spinal nerves. Venous drainage occurs through meningeal veins that accompany the arteries and through the dural venous sinuses in the cranium. The rich vascular network of the dura, combined with its dense sensory innervation, makes it a metabolically active and highly responsive tissue, capable of mounting robust inflammatory and neurogenic responses to injury or infection.
3.5 Cerebrospinal Fluid Dynamics and the Subarachnoid Space
The subarachnoid space, located between the arachnoid and pia mater, is filled with cerebrospinal fluid and serves as a critical compartment for central nervous system protection, nourishment, and waste removal. Cerebrospinal fluid is produced primarily by the choroid plexuses within the cerebral ventricles, with the lateral ventricles serving as the dominant contributors. The classical model attributes approximately 80 percent of cerebrospinal fluid production to the choroid plexus and 20 percent to the blood-brain barrier endothelium, though revised models describe additional extrachoroidal sources including transendothelial influx of fluid across the blood-brain barrier driven by ion and solute cotransporters. The rate of cerebrospinal fluid formation in humans is approximately 0.3 to 0.4 milliliters per minute, resulting in the production of 500 to 700 milliliters per day, while the total cerebrospinal fluid volume at any given time averages 150 to 270 milliliters in adults. This means the entire volume of cerebrospinal fluid is replaced approximately four times per day, a remarkable turnover rate that underscores the importance of efficient production and absorption mechanisms.
Cerebrospinal fluid flows through the ventricular system in a unidirectional, rostral-to-caudal manner, beginning in the lateral ventricles and proceeding through the interventricular foramina of Monro into the third ventricle, then through the cerebral aqueduct of Sylvius into the fourth ventricle. From the fourth ventricle, cerebrospinal fluid exits via the median aperture of Magendie and the paired lateral apertures of Luschka into the subarachnoid space at the base of the brain. Once within the subarachnoid space, cerebrospinal fluid exhibits gentle multidirectional flow that promotes equilibration of composition throughout the compartment, circulating over the cerebral convexities and along the spinal cord while maintaining continuous exchange across interstitial and perivascular interfaces. The motor force driving this flow comes from constant production at the choroid plexus, arterial pulsation of central nervous system structures, venous pulsation related to the respiratory cycle, and constant reabsorption at the arachnoid granulations.
The classical theory holds that cerebrospinal fluid absorption occurs primarily via arachnoid villi and granulations, which are protrusions of arachnoid mater that extend through the dura mater into the lumen of venous sinuses. A pressure gradient of 3 to 5 millimeters of mercury between the subarachnoid space and venous sinuses drives cerebrospinal fluid into the venous system through these structures. However, contemporary models have significantly revised this understanding, recognizing that dorsal and basal dural lymphatic vessels now appear to serve as major outflow pathways, draining cerebrospinal fluid to cervical lymph nodes. Additional clearance routes include perineural pathways along cranial nerves, particularly through the nasal cribriform plate, and spinal nerve root sheaths draining into paravertebral lymphatics and the epidural venous plexus. Cerebrospinal fluid also traverses the adventitia of basal cerebral arteries to reach perivascular lymphatic vessels. These multiple drainage pathways operate in parallel, with their relative contributions varying depending on physiological state, age, and pathological conditions.
The Virchow-Robin spaces, perivascular compartments surrounding blood vessels penetrating from the subarachnoid space into the brain parenchyma, represent critical interfaces for fluid exchange between cerebrospinal fluid and interstitial fluid. The microscopic anatomy of these spaces is complex, built upon endothelial, pial, and glial cell layers each delineated by distinct basement membranes. The glial membrane covering the brain parenchyma forms the outer wall of the Virchow-Robin space, while at the capillary bed the basement membranes of glia and endothelium fuse, obliterating the space. Arterial vessels within the cortical subarachnoid space are covered with a pial cell layer that creates a perivascular space next to the vessel wall, and this pial sheath extends into the Virchow-Robin space, becoming progressively more fenestrated and leakier near the capillary bed. Experimental evidence indicates that solutes and fluid may be drained from the brain interstitium along the basement membranes of capillaries and arteries into the cervical lymphatics, a pathway that may be obstructed by amyloid deposition in cerebral amyloid angiopathy and Alzheimer's disease.
3.6 The Meningeal Lymphatic System and Glymphatic Pathways
The rediscovery of meningeal lymphatic vessels in 2015 by researchers using lymphatic endothelial cell-specific fluorescent reporters and immunofluorescent staining fundamentally challenged the long-standing dogma that the central nervous system lacks a lymphatic system. Meningeal lymphatic vessels are located in the dura mater, aligned alongside arteries, major venous sinuses, and cranial nerves, and appear to provide a pathway for drainage out from the cranium via the various foramina at the base of the skull. Lymphatic vessels under the olfactory bulb cross the cribriform plate, where olfactory nerves travel through bone into the nasal mucosa, providing an additional drainage route. Compared with the superior portions of the skull, the dural lymphatic network in the basal parts is more extensive and contains valves, though the functional significance of these valves remains unclear given that fluid outflow from the head is ensured by gravity.
The physiological functions of the meningeal lymphatic vessels are multifaceted and extend far beyond simple fluid drainage. They serve as essential components of central nervous system immune surveillance, transporting immune cells and corresponding antigens from the brain parenchyma and meningeal compartment to the peripheral immune system. Meningeal T cells provide immune surveillance by traveling through the cerebrospinal fluid to patrol central nervous system-associated border regions and detect pathogenic alterations. The meningeal lymphatic vessels have been shown to transport T cells and dendritic cells from the central nervous system to deep cervical lymph nodes, enabling the activation of peripheral immune responses against brain-derived antigens. Through the glymphatic-meningeal lymphatic system, immune cells and central nervous system-derived antigens can drain from the brain parenchyma into the cerebrospinal fluid and finally into the peripheral immune system, guaranteeing that the central nervous system is not ignored by the immune system.
The glymphatic system, a brain-wide waste clearance network mediated by astrocyte-dependent cerebrospinal fluid-interstitial fluid exchange, works in close coordination with the meningeal lymphatic vessels. Fresh cerebrospinal fluid flows into the brain parenchyma along arterial perivascular spaces, where it is exchanged with interstitial fluid. The mixed cerebrospinal fluid-interstitial fluid then flows toward venous perivascular spaces and perineuronal spaces, clearing waste products and excess fluid into meningeal and cervical lymphatic vessels. Aquaporin-4 water channels expressed on astrocytic endfeet are critical for this fluid exchange, and their dysfunction impairs glymphatic clearance. The glymphatic system also plays key roles in brain function by transporting bulk volume, carrying neuropeptides from the hypothalamus to other parts of the brain to regulate eating, drinking, body temperature, neuroendocrine release, and circadian timing.
Dysfunction of the glymphatic-meningeal lymphatic system has been implicated in the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease. Impaired meningeal lymphatics induce aberrant activation of microglia in mouse models of Alzheimer's disease, while disease-associated inflammatory macrophages expressing inflammation-related genes are present in the leptomeninges of both transgenic mouse models and human Alzheimer's disease patients. The apolipoprotein E epsilon 4 allele disrupts meningeal lymphatic function, increasing Alzheimer's disease risk via amyloid-beta clearance deficits. Aging is linked to a gradual decline in these clearance pathways, resulting in waste buildup that may drive neurodegeneration. Emerging therapeutic strategies targeting cerebral lymphatic function have garnered growing interest, including pharmacological methods to stimulate meningeal lymphatic regeneration, cervical deep lymphaticovenous anastomosis, and non-invasive mechanical stimulation of cervical lymphatics to enhance cerebrospinal fluid drainage. Non-invasive mechanical stimulation of the lymphatics under the skin on the neck and face has been shown to significantly enhance cerebrospinal fluid flow through lymphatic vessels, offering a promising new approach to clearing brain waste without drugs or surgical interventions.
3.7 Meningeal Immunity and Neuroimmune Interactions
The meninges have emerged as a critical neuroimmune interface, hosting diverse immune cell populations that participate in central nervous system surveillance, defense, and homeostatic regulation. For decades, the central nervous system was considered an immune-privileged site, isolated from peripheral immune influences by the blood-brain barrier, with microglia seen as the only permanent immune cells in healthy brain parenchyma. The discovery of lymphatic structures within the meninges and the recognition of extensive immune cell populations in the dura mater have challenged this concept, necessitating a reevaluation of the meninges' role in central nervous system and immune functions. The meninges are now recognized not as a mere protective barrier or wall, but as a bridge—a dynamic microenvironment hosting diverse immune cell populations with specialized roles in maintaining brain homeostasis in both health and disease.
The dural sinuses have been identified as immune hubs where circulating T cells constantly access central nervous system-enriched antigens with the help of local antigen-presenting cells, allowing homeostatic immune surveillance. Single-cell RNA sequencing combined with ligand-receptor inference analysis has revealed both physical and signaling interactions between dural stromal cells and immune populations. The CXCL12-CXCR4 signaling axis contributes greatly to the recruitment of circulating T cells into the dura. After adhesion and arrest mediated by high adhesion molecule expression on the dural sinus endothelium, T cells extravasate through the dural sinuses, accumulate in proximity to the sinuses, and are steadily replenished from the periphery. Central nervous system-derived antigens in the cerebrospinal fluid drain into the perisinusal dura and are captured by sinus-associated antigen-presenting cells, which are identified as macrophages and dendritic cells based on their high expression of major histocompatibility complex class II. The T cells interact with these antigen-presenting cells, recognize cognate antigens, and display tissue-resident phenotypes and effector functions, enabling efficient immune surveillance of the central nervous system in homeostasis. This perisinusal localization of antigen-presenting cells and accumulation of brain-enriched proteins have also been observed in human postmortem samples, suggesting the presence of shared mechanisms underlying immune surveillance at the dural sinuses.
A particularly striking discovery has been the identification of dural-associated lymphoid tissues, organized lymphoid structures within the dura of mice and humans that are intricately interwoven with the fenestrated vasculature of the dura. The most complex components are located in the rostral-rhinal and basal olfactory venous hubs, which host diverse immune cell populations including various B cell subsets, plasma cells, T follicular helper cells, and T follicular regulatory cells. During pathogen invasion, interactions between germinal center B cells and T follicular helper cells are intensified, and B cells activated within dural-associated lymphoid tissues subsequently migrate to the sinus wall, bolstering local immunity. These venous lymphoid hubs facilitate rapid expansion of antigen-specific immune responses, potentially offering defense against foreign pathogens threatening the central nervous system parenchyma. This discovery presents a novel model for understanding central nervous system immunosurveillance and challenges the traditional view of the meninges as a simple barrier.
The skull-meninges interface represents another novel paradigm in neuroimmunology. Small transosseous vessels connecting the skull and the meninges, linking the dural venous system with the diploic venous system, were discovered in 2018. In the calvaria of adult mice, approximately one thousand channels connect the dura with the calvarial bone marrow, measuring about 80 to 100 micrometers in length and 20 micrometers in diameter. Many immune cells in the dura come from skull and spine bone marrow rather than blood, traveling along blood vessel surfaces and through these tiny bone channels to reach the dura. The bone marrow in the calvaria and vertebrae plays a crucial role in supplying monocytes and neutrophils to the dura under normal conditions, and following brain injury or during neuroinflammation, it provides these cells to both the meninges and brain parenchyma. Single-cell transcriptomic studies have revealed that the skull and vertebrae house both developing and mature immune cells, mirroring the composition found in the tibial niche, though subtle yet significant differences exist between immune cells from the calvaria and tibia. The skull-meninges channels enable direct communication between the skull and meninges, facilitating immune cell migration independent of systemic circulation.
The distribution of immune cells is not uniform across the meningeal layers. The outermost dura exhibits greater immune cell heterogeneity compared to the inner leptomeninges, which contain fewer cell types and numbers, primarily consisting of macrophages, dendritic cells, and mast cells. The healthy meninges harbor a wide array of immune cells including various types of innate lymphoid cells, B cells, T cells, monocytes, macrophages, dendritic cells, mast cells, plasma cells, and neutrophils. These populations are dynamic, undergoing changes in diversity and composition during aging, inflammation, and neurodegenerative conditions. During aging, dural T cells increase in number, skew toward non-sinus regions, and enhance interferon-gamma expression, while age-associated B cells derived from the blood accumulate in the dura, show antigen-experienced patterns, and undergo differentiation into plasma cells. Disease-associated inflammatory macrophages highly expressing inflammation-related genes increase in number during aging, and dural stromal populations upregulate adhesion molecules and extracellular matrix at non-sinus sites.
3.8 Meningeal Contributions to Neurological Disease
The involvement of meningeal immunity in neurological diseases has been extensively studied, particularly in multiple sclerosis, where a strikingly different contribution of each meningeal layer to central nervous system autoimmunity has been identified. A substantial infiltration of myeloid and T cells has been observed in the spinal cord leptomeninges and parenchyma in experimental autoimmune encephalomyelitis models, whereas the dura presented sparse inflammation. A similar scenario was observed in patients with chronic multiple sclerosis. The infiltration of antigen-specific T cells was less prominent in the dura than in the leptomeninges in all stages of experimental autoimmune encephalomyelitis, and the activation level of effector T cells was also lower in the dura, regardless of the induced models or species. Despite the higher permeability of the dural vasculature, interactions between pathogenic T cells and vascular endothelium were weaker in the dura than in the leptomeninges, partly explained by the lower expression of tight junction molecules and firm adhesion factors in the dural vasculature. Dural antigen-presenting cells could present antigens but required additional autoantigen administration to evoke their full stimulatory potential, whereas leptomeningeal antigen-presenting cells exhibited full competence and spontaneously induced T cell activation. These findings compellingly reshape our concept of the meningeal role in central nervous system autoimmunity, demonstrating that the leptomeninges are the primary site of autoimmune inflammation while the dura serves a more regulatory function.
In Alzheimer's disease, impaired meningeal lymphatics induce aberrant activation of microglia in mouse models, while disease-associated inflammatory macrophages are present in the leptomeninges of both transgenic mice and human patients. The glymphatic system dysfunction that characterizes Alzheimer's disease pathogenesis is intimately linked to meningeal lymphatic impairment, creating a vicious cycle in which reduced clearance of amyloid-beta and tau proteins drives neuroinflammation and neurodegeneration. The apolipoprotein E epsilon 4 genotype, the strongest genetic risk factor for sporadic Alzheimer's disease, disrupts meningeal lymphatic function and increases disease risk via amyloid-beta clearance deficits. Diffusion tensor imaging along the perivascular space and dynamic magnetic resonance imaging now enable non-invasive detection of glymphatic dysfunction, offering potential for pre-symptomatic intervention.
Meningeal inflammation also plays a role in infectious diseases of the central nervous system. Bacteria such as Streptococcus pneumoniae and Streptococcus agalactiae can utilize meningeal neuronal pathways, exploiting nociceptors responsible for pain signaling to gain central nervous system access. Genetically engineered mice lacking these receptors show reduced bacterial loads and diminished inflammatory responses in meningitis models, suggesting that the neuroimmune axis of the meninges may be hijacked by pathogens to facilitate brain invasion. This mechanism highlights the dual-edged nature of meningeal neuroimmune interactions: the same pathways that enable immune surveillance can be exploited by pathogens to breach central nervous system defenses.
3.9 Clinical Disorders of the Meninges
Meningitis, the inflammation of the meninges, represents one of the most serious infectious emergencies in medicine. Bacterial meningitis develops when organisms colonizing the nasopharynx penetrate the mucosa and enter the bloodstream, subsequently crossing the blood-brain barrier to reach the subarachnoid space where they replicate and trigger inflammation. The most common bacterial pathogens include Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, and Streptococcus agalactiae, though the specific etiology varies with age and immune status. The host immune response generates a complex cascade involving interleukin-1, interleukin-6, tumor necrosis factor, reactive oxygen intermediates, and matrix metalloproteinases, which disrupt the blood-brain barrier, generate cerebral edema, and cause global and focal ischemia that contributes to structural and functional brain injury. Viral meningitis, most commonly caused by nonpolio enteroviruses, follows a similar sequence of initial infection followed by secondary viremia that seeds the central nervous system, though the inflammatory response is generally less severe. A recently published survey of meningitis in the United States found enterovirus as the predominant cause at 51 percent, with bacterial meningitis accounting for 14 percent of total cases. The remaining identified infectious causes included herpes simplex virus, fungal pathogens, arboviruses, and other viruses, with 21 percent classified as unknown and 3.5 percent as noninfectious.
The diagnosis of meningitis relies on clinical recognition of the classic triad of headache, fever, and nuchal rigidity, supplemented by lumbar puncture for cerebrospinal fluid analysis. The spinal subarachnoid space, specifically the lumbar cistern inferior to the conus medullaris, is the preferred site for diagnostic lumbar puncture, typically performed at the L3-L4 interspace. The needle passes through the skin, subcutaneous tissue, supraspinous ligament, interspinous ligament, ligamentum flavum, epidural space, dura mater, arachnoid mater, and finally into the subarachnoid space. Cerebrospinal fluid analysis demonstrates characteristic findings including pleocytosis, elevated protein, and altered glucose levels, with the specific pattern helping to distinguish bacterial from viral, fungal, and tuberculous etiologies. Neuroimaging, preferably magnetic resonance imaging with contrast, is essential for identifying complications such as hydrocephalus, cerebral abscess, or venous sinus thrombosis.
Subdural hematoma results from bleeding beneath the dura mater, most commonly due to rupture of bridging veins exposed to shearing forces during head trauma. The usual mechanism involves high-speed impact to the skull that causes brain tissue to accelerate or decelerate relative to the fixed dural structures, tearing the bridging veins that connect the cortical surface of the brain to dural sinuses. In elderly persons, the bridging veins may already be stretched because of brain atrophy, making them particularly vulnerable to even minor trauma. Low-pressure venous bleeding from bridging veins dissects the arachnoid away from the dura, and the blood layers out along the cerebral convexity, creating the characteristic crescent-shaped collection on computed tomography imaging. With sufficient blood accumulation, the cerebral midline shifts toward the contralateral side, compressing brain structures and potentially causing cerebral herniation. Chronic subdural hematoma is commonly associated with cerebral atrophy, where cortical bridging veins are under greater tension as the brain gradually shrinks from the skull, and even minor trauma may cause one of these veins to tear. The coagulation and fibrinolysis systems are both excessively activated in chronic subdural hematoma, resulting in defective clot formation and recurrent hemorrhage that contributes to hematoma expansion.
Leptomeningeal disease, also known as leptomeningeal carcinomatosis or neoplastic meningitis, refers to the spread of malignant cells to the leptomeninges and cerebrospinal fluid. It represents a devastating complication of systemic cancers including breast cancer, lung cancer, melanoma, and hematological malignancies. Diagnosis relies on magnetic resonance imaging of the brain and spine with contrast enhancement, which is the preferred imaging method, supplemented by cerebrospinal fluid cytology which remains the gold standard despite its limited sensitivity from a single sample. Typical magnetic resonance imaging findings include contrast enhancement of cerebellar folia and sulci, basilar cisterns, cranial nerves, brain surface, and the surface of the lateral ventricles. The Response Assessment in Neuro-Oncology criteria for leptomeningeal disease have been proposed to standardize radiographic assessment, though their use in routine clinical practice has been limited by complexity. Treatment options include intrathecal chemotherapy, systemic therapy, radiation therapy, and supportive care, though prognosis remains poor with median survival typically measured in months.
Meningiomas are the most common primary intracranial neoplasms, accounting for more than one-third of primary central nervous system tumors and approximately 60 percent of benign central nervous system tumors. While traditionally viewed as benign, meningiomas can be associated with considerable morbidity, and specific subgroups display more aggressive behavior with higher recurrence rates. The fifth edition of the 2021 World Health Organization Classification of Central Nervous System Tumors stratifies meningioma into three grades based on histopathology criteria and molecular profile. The most common molecular alteration is the loss of one copy of chromosome 22 or alteration of the neurofibromatosis type 2 gene, present in 40 to 60 percent of sporadic meningiomas. Mutations in tumor necrosis factor receptor-associated factor 7 are the second most common alteration, found in 25 percent of tumors, and are exclusive to meningiomas without neurofibromatosis type 2 alterations. Tumor location correlates with underlying mutations: cerebral convexity and most spinal meningiomas carry 22q deletion and neurofibromatosis type 2 mutations, while skull base meningiomas typically have AKT1, tumor necrosis factor receptor-associated factor 7, smoothened, and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha mutations. The telomerase reverse transcriptase promoter mutations and cyclin-dependent kinase inhibitor 2A-B deletions now signify grade 3 meningioma with increased recurrence risk. Molecular profiling has enabled the development of targeted therapies, with inhibitors of the PI3K-AKT pathway, Hedgehog pathway, and receptor tyrosine kinases under investigation for recurrent or aggressive meningiomas.
3.10 Emerging Therapeutic Strategies Targeting Meningeal Pathways
The evolving understanding of meningeal biology has opened numerous avenues for therapeutic intervention across neurological diseases. In Alzheimer's disease, strategies targeting glymphatic enhancement include aquaporin-4 modulation, meningeal lymphatic regeneration through vascular endothelial growth factor-C therapy, and cervical deep lymphaticovenous anastomosis. Non-pharmacological approaches such as sleep optimization and physical exercise support efficient lymphatic removal of waste products from the brain, as sleep and arterial pulsatility critically regulate glymphatic efficiency. Photobiomodulation, using non-invasive light therapy, has shown promise for stimulating brain drainage and clearance and improving cognitive impairment during Alzheimer's disease progression. The innovative method of improving anti-amyloid-beta immunotherapy efficacy by stimulating meningeal lymphatic vessel growth represents a particularly exciting direction, as it could enhance the clearance of antibody-bound amyloid-beta complexes from the brain.
In meningioma, the molecular classification of tumors based on neurofibromatosis type 2, tumor necrosis factor receptor-associated factor 7, AKT1, and other driver mutations is guiding the development of targeted therapies. Tumor necrosis factor receptor-associated factor 7-associated meningiomas, along with neurofibromatosis type 2 and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha-associated tumors, are more aggressive and recur at significantly higher rates than other molecular subgroups, identifying patients who may benefit from more aggressive initial treatment or novel therapeutic approaches. The recognition that specific mutations correlate with anatomical location enables personalized surgical planning and prognostication.
For neuroinflammatory diseases such as multiple sclerosis, understanding the differential involvement of dural versus leptomeningeal compartments in autoimmune inflammation may lead to compartment-specific therapies that target the primary sites of pathology while sparing regulatory functions elsewhere. The dural-associated lymphoid tissues represent potential targets for immunomodulation, as these structures coordinate antigen-specific B cell responses that may contribute to disease pathogenesis or, conversely, could be harnessed for therapeutic vaccination strategies.
4. Discussion
The field of meningeal biology has undergone a revolutionary transformation, evolving from a discipline focused on gross anatomical description to a vibrant area of research at the intersection of neuroscience, immunology, and vascular biology. The evidence synthesized in this review establishes the meninges as far more than passive protective coverings; they are dynamic, multifunctional tissues that actively participate in central nervous system homeostasis, immune surveillance, waste clearance, and neurodevelopment. The molecular and cellular complexity of the meninges, as revealed by single-cell transcriptomics and advanced imaging, rivals that of many other organ systems, and the structural specializations discovered in recent years—including meningeal lymphatic vessels, dural-associated lymphoid tissues, arachnoid cuff exit points, and skull-meninges channels—have fundamentally reshaped our understanding of how the brain interacts with the rest of the body.
Several themes emerge from this synthesis that have important implications for both research and clinical practice. First, the traditional view of the central nervous system as an immune-privileged site, isolated from peripheral immune influences by the blood-brain barrier, is no longer tenable. The meninges serve as a critical bridge between the brain and the peripheral immune system, enabling continuous immune surveillance, antigen presentation, and immune cell trafficking that are essential for central nervous system health. The dural sinuses function as immune hubs where circulating T cells sample central nervous system-derived antigens, and the dural-associated lymphoid tissues generate localized immune responses that can be mobilized against pathogens threatening the brain. This neuroimmune interface is not merely a defensive structure but an active participant in shaping brain function, with meningeal-derived cytokines, chemokines, and growth factors influencing neuronal connectivity, learning, and memory.
Second, the glymphatic-meningeal lymphatic system represents a paradigm shift in our understanding of brain waste clearance and fluid homeostasis. The discovery that cerebrospinal fluid drains through meningeal lymphatic vessels to cervical lymph nodes, rather than being absorbed primarily through arachnoid granulations into venous blood, has profound implications for the pathophysiology of neurodegenerative diseases. The impairment of this clearance system with aging, and its genetic susceptibility in carriers of the apolipoprotein E epsilon 4 allele, provides a mechanistic link between aging, genetics, and Alzheimer's disease risk that may be amenable to therapeutic intervention. The development of non-invasive methods to enhance glymphatic and lymphatic clearance, including mechanical stimulation of cervical lymphatics and photobiomodulation, offers promising avenues for preventing or delaying neurodegeneration.
Third, the regional heterogeneity of meningeal structure and function, rooted in distinct embryological origins and maintained by molecularly distinct fibroblast populations, explains many clinical observations that have long puzzled neurologists and neurosurgeons. The differential susceptibility of forebrain versus hindbrain meninges to certain pathologies, the preferential distribution of specific meningioma subtypes, and the varying patterns of meningeal inflammation in autoimmune diseases all reflect underlying biological specializations that are only now being elucidated. This regional diversity also has practical implications for diagnostic sampling, therapeutic targeting, and surgical approaches.
Fourth, the skull-meninges interface as a source of immune cells and a conduit for central nervous system-peripheral communication represents a novel therapeutic target. The recognition that cranial bone marrow supplies monocytes and neutrophils to the dura through transosseous channels, independent of systemic circulation, suggests that modulating this local hematopoietic niche could influence meningeal immune responses in stroke, trauma, and neurodegenerative disease. The potential for skull-directed therapies that enhance or suppress local immune cell production offers a new dimension to neuroimmunomodulation.
Despite these advances, significant challenges remain in translating meningeal biology into clinical practice. The complexity of meningeal anatomy, with its multiple layers, spaces, and specialized structures, complicates both diagnostic imaging and therapeutic delivery. The blood-meningeal barrier, while more permeable than the blood-brain barrier, still limits drug access to meningeal compartments. The heterogeneity of meningeal immune cell populations, which change dynamically with age and disease state, makes targeted immunomodulation difficult. Furthermore, much of our current understanding derives from animal models, and species differences in meningeal anatomy, lymphatic distribution, and immune cell composition may limit translational relevance.
Methodological limitations in current research also warrant acknowledgment. The thinness and fragility of meningeal layers make them challenging to study with conventional histological techniques, and the development of whole-mount immunohistochemistry, tissue clearing methods such as vDISCO and wildDISCO, and three-dimensional spatial transcriptomics has been essential for recent advances. In vivo imaging of meningeal structures in humans remains limited, though dynamic magnetic resonance imaging and diffusion tensor imaging along the perivascular space are promising non-invasive approaches. The clinical validation of preclinical findings, particularly regarding meningeal lymphatic function and immune cell trafficking, requires larger prospective studies with standardized methodologies.
5. Conclusion
The meninges have emerged from obscurity as a central focus of contemporary neuroscience, revealed as a dynamic, multifunctional interface essential for central nervous system homeostasis, immune surveillance, waste clearance, and neurodevelopment. The three classical layers—dura mater, arachnoid mater, and pia mater—contain within them a remarkable diversity of cellular populations, structural specializations, and molecular pathways that coordinate to protect and support the brain and spinal cord. The rediscovery of meningeal lymphatic vessels, the identification of dural-associated lymphoid tissues, the characterization of arachnoid cuff exit points, and the elucidation of skull-meninges channels have collectively transformed our understanding of how the central nervous system communicates with the peripheral immune system and clears metabolic waste. The integration of meningeal lymphatics with the glymphatic system provides a unified framework for understanding brain fluid dynamics and their disruption in aging and neurodegenerative disease.
Clinically, these advances are reshaping approaches to meningitis, subdural hematoma, leptomeningeal disease, and meningioma, while opening entirely new therapeutic avenues for Alzheimer's disease, multiple sclerosis, and other neurological disorders. The molecular classification of meningiomas based on neurofibromatosis type 2, tumor necrosis factor receptor-associated factor 7, and other driver mutations is already guiding personalized treatment decisions, and targeted therapies modulating meningeal immune responses and lymphatic function are in active development. Looking forward, the continued application of single-cell genomics, advanced imaging, and microphysiological systems promises to further illuminate the complexity of meningeal biology and to accelerate the translation of mechanistic insights into clinical benefit. As our understanding continues to deepen, the meninges will increasingly be recognized not merely as protective coverings, but as an active, intelligent interface that is indispensable for brain health and a promising target for neurological therapeutics.
References
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341. doi:10.1038/nature14432
Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991-999. doi:10.1084/jem.20142290
Louveau A, Herz J, Alme MN, et al. CNS lymphatic drainage and neuroimmunology: Lessons from learning and memory. Sci Immunol. 2017;2(41):eaal3235. doi:10.1126/sciimmunol.aal3235
Albayram MS, Smith G, Tufan F, et al. Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes. Nat Commun. 2022;13(1):203. doi:10.1038/s41467-021-27887-1
Louveau A, Plog BA, Antila S, et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127(9):3210-3219. doi:10.1172/JCI90603
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111. doi:10.1126/scitranslmed.3003748
Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The Glymphatic System: A Beginner's Guide. Neurochem Res. 2015;40(12):2583-2599. doi:10.1007/s11064-015-1581-6
Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018;560(7717):185-191. doi:10.1038/s41586-018-0368-8
Da Mesquita S, Herz J, Wall M, et al. Aging-associated deficit in CCR7 is linked to worsened glymphatic function, cognition, and neuroinflammation, and can be rescued in mice by blocking endothelial signaling. Nat Aging. 2021;1(8):731-740. doi:10.1038/s43587-021-00090-6
Ahn JH, Cho H, Kim JH, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572(7767):62-66. doi:10.1038/s41586-019-1419-5
Antila S, Karaman S, Nurmi H, et al. Development and plasticity of meningeal lymphatic vessels. J Exp Med. 2017;214(12):3645-3667. doi:10.1084/jem.20170391
Louveau A, Harris TH, Kipnis J. Revisiting the concept of CNS as immune-privileged site: T lymphocytes and new insights. CNS Neurol Disord Drug Targets. 2015;14(9):1164-1167. doi:10.2174/1871527315666151111123006
Louveau A, Herz J, Alme MN, et al. CNS lymphatic drainage and neuroimmunology: Lessons from learning and memory. Sci Immunol. 2017;2(41):eaal3235. doi:10.1126/sciimmunol.aal3235
Cugurra A, Mamuladze T, Rustenhoven J, et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and central nervous system. Nat Neurosci. 2021;24(8):1101-1109. doi:10.1038/s41593-021-00896-4
Herisson F, Frodermann V, Courties G, et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci. 2018;21(9):1209-1217. doi:10.1038/s41593-018-0214-2
Rustenhoven J, Drieu A, Mamuladze T, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184(4):1000-1016.e27. doi:10.1016/j.cell.2020.12.040
Alves de Lima K, Rustenhoven J, Da Mesquita S, et al. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat Immunol. 2020;21(11):1421-1429. doi:10.1038/s41590-020-0776-4
Fitzpatrick Z, Frazer G, Ferro A, et al. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature. 2020;587(7834):472-476. doi:10.1038/s41586-020-2886-4
Mazzitelli JA, Smyth LCD, Cross KA, et al. Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat Neurosci. 2022;25(4):555-560. doi:10.1038/s41593-022-01430-1
Kim K, Wang X, Gallan AJ, et al. Meningeal immunity in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain. 2022;145(12):4210-4226. doi:10.1093/brain/awac335
Hladky SB, Barrand MA. Fluid and ion transfer across the blood–brain and blood–cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. 2016;13(1):19. doi:10.1186/s12987-016-0040-2
Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11:10. doi:10.1186/2045-8118-11-10
Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009;117(1):1-14. doi:10.1007/s00401-008-0457-0
Weller RO, Sharp MM, Christodoulides M, Carare RO, Mollgard K. The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS. Acta Neuropathol. 2018;135(3):363-385. doi:10.1007/s00401-018-1807-z
Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31(4):497-511. doi:10.1007/s00281-009-0177-0
Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33(12):579-589. doi:10.1016/j.it.2012.07.004